Evidence map›Paper›PMID 28913154›Full record

ArticleAmerican journal of nuclear medicine and molecular imaging2017

PET/CT imaging of the diapeutic alkylphosphocholine analog

Lance T Hall, Benjamin Titz, H Ian Robins, Bryan P Bednarz, Scott B Perlman, Jamey P Weichert, John S Kuo

Registry-linked trialAbstract read
PubMed Full text at PMC
In one paragraph

Article in American journal of nuclear medicine and molecular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01540513 (PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01540513 nacompletednot on this map

PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404

TypeinterventionalSponsorUniversity of Wisconsin, MadisonRan2012 to 2014Enrolled12ConditionsGlioblastoma Multiforme, Brain MetastasesArmsNM404
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. [Molecular imaging and biology · 2020
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lance T HallDepartment of Radiology, University of WisconsinMadison, WI, USA.
Benjamin TitzCellectar Biosciences, IncMadison, WI, USA.
H Ian RobinsDepartment of Human Oncology, University of WisconsinMadison, WI, USA.
Bryan P BednarzDepartment of Medical Physics, University of WisconsinMadison, WI, USA.
Scott B PerlmanDepartment of Radiology, University of WisconsinMadison, WI, USA.
Jamey P WeichertDepartment of Radiology, University of WisconsinMadison, WI, USA.
John S KuoDepartment of Human Oncology, University of WisconsinMadison, WI, USA.

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
PET/CT Imaging of Malignant Brain Tumors with 124I-NM404R01CA158800 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI HALL, LANCE T, WEICHERT, JAMEY P · 2011 to 2014
$1.2M
NCATS NIH HHS UL1 TR000427NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA158800
6 · The paper itself

Abstract

CLR1404 is a cancer-selective alkyl phosphocholine (APC) analog that can be radiolabeled with

Indexed as

alkyl phosphocholine analogbrain tumorCLR1404high grade brain tumorlow grade brain tumormolecular imagingPET

Identifiers

PMID28913154
PMCPMC5596318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.